WOBURN, Mass., April 21, 2026 (GLOBE NEWSWIRE)-- Curiox Biosystems today announced the signing of a Master Software License Agreement with a major global pharmaceutical organization for the deployment ...

Find the Curiox BioSystems financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial reports, including the ...

New software for Pluto Workstation automates cocktailing, staining, and centrifuge-free washing — running the lab’s existing SOP without coding ...

Leading AI-Powered Immune Profiling Company IMU to Adopt Pluto Workstation for Large-Scale Immune Phenotyping Project Based on UK Patient Big Data SEOUL, South Korea, May 15, 2025 (GLOBE NEWSWIRE) -- ...

The share price of Curiox Biosystems has surged significantly this year. Despite expectations of a large operating loss again this year, the company's corporate value is rising on the back of strong ...

Curiox BioSystems (445680) has delivered a 137% change over the past year, with a 52-week range between 31,050 and 149,200. What Is the Average Daily Trading Volume of Curiox BioSystems (445680)? The ...

Curiox Biosystems, a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis, is pleased to announce its collaboration with Dr.

The Curiox C- Free Pluto ALPHA replaces traditional centrifuge-based methods, offering a low-maintenance solution that eliminates bulky hardware. Utilizing a pipette head, it delivers gentle, ...

First master licensing framework for Pluto Code enables a global pharmaceutical organization to expand centrifuge-free automation across its liquid-handling infrastructure without repeated contracting ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...